Morgan / Northwestern Now, 20242026 What Independent Operators Should Do Now The chains adapting to GLP-1 have full analytics teams, national POS data, and product development cycles measured in months
Your provider will recommend the best infusion rate based on your treatment and health goals
Conversely, if you are on injections but struggling with side effects, switching to drops might provide adequate results with better tolerability
Rather than focusing solely on tissue expansion, modern peptide investigations increasingly emphasize coordinated repair signaling and molecular adaptation mechanisms
Ask about pregnancy or breastfeeding, liver or kidney disease, autoimmune conditions, blood-thinning medications, diabetes, active skin infections in the treatment area, recent injectable treatments (past 4 weeks), allergies to bromelain, lecithin, or riboflavin, current medications, keloid scarring history, and thyroid conditions